Multi Medika Internasional Raih Pembiayaan Rp 60 Miliar dari Bank Aladin - KONTAN
| MMIX Stock | 77.00 2.00 2.53% |
About 62% of Multi Medika's investor base is looking to short. The analysis of current outlook of investing in Multi Medika Internasional suggests that many traders are alarmed regarding Multi Medika's prospects. Multi Medika's investing sentiment shows overall attitude of investors towards Multi Medika Internasional.
Multi |
Multi Medika Internasional Raih Pembiayaan Rp 60 Miliar dari Bank Aladin KONTAN
Read at news.google.com
 |
Multi Medika Fundamental Analysis
We analyze Multi Medika's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Multi Medika using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Multi Medika based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Multi Medika is regarded third in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Multi Medika Interna Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Multi Medika stock to make a market-neutral strategy. Peer analysis of Multi Medika could also be used in its relative valuation, which is a method of valuing Multi Medika by comparing valuation metrics with similar companies.
Peers
Multi Medika Related Equities
| MICE | Multi Indocitra | 2.97 | ||||
| MAGP | Multi Agro | 0.00 | ||||
| MLBI | Multi Bintang | 0.79 | ||||
| LPIN | Multi Prima | 0.99 | ||||
| MMIX | Multi Medika | 2.53 |
Other Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.